Enhanced cardiac sympathetic afferent reflex in CHF
Enhanced cardiac sympathetic afferent reflex in CHF
批准号:
6815913
负责人:
WEI WANG
金额:
$24.13万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-01 至 2004-10-31
关键词:
afferent nerveangiotensin IIbaroreceptorsbaroreflexbiological modelscardiovascular functionchemoreceptorscongestive heart failureexercisefree radical oxygenfree radicalsheart pharmacologyhormone regulation /control mechanismlaboratory ratlidocainemyocardial ischemia /hypoxianeuropathologyneuropharmacologyneuroregulationneurotoxinsneurotransmittersoxidative stressoxidizing agentsreflexsympathetic nervous system
中文摘要
描述(由申请人提供):心衰的特征是交感神经张力升高。心衰中交感神经兴奋的机制尚不完全清楚。本实验室最近的研究表明,心力衰竭时心脏“交感传入”反射增强,压力感受器反射减弱。心衰时心脏交感传入反射增强和压力感受器反射减弱是由中央血管紧张素II升高介导的。到目前为止,导致心力衰竭状态下这些反射相互作用的机制尚不完全清楚。根据初步数据,我们假设心脏交感传入反射的增强是由心衰状态下的中枢血管紧张素II和反应性氧化应激介导的。为了更好地了解心脏交感传入反射增强的机制,我们提出以下具体目标:1)确定在心力衰竭中活性氧是否通过中枢血管紧张素II升高介导心脏交感传入反射增强;2)确定心脏交感神经传入反射是否使压力感受器反射钝化,以及心力衰竭动物的钝化压力反射是否通过心外膜应用利多卡因去除心脏交感神经传入输入或心外膜应用超强神经毒素树脂干扰素消耗心脏交感神经传入神经递质而恢复。心衰大鼠中枢血管紧张素II和自由基是否通过激活心脏交感传入通路在压力感受器反射钝化中起重要作用;3)通过心外膜应用利多卡因或树脂干扰素去除心脏交感传入输入,确定心衰动物的交感传入反射是否增强了化学受体反射,以及增强的化学受体反射是否恢复,并确定心衰大鼠的中枢血管紧张素II和自由基是否通过激活心脏交感传入而在化学受体反射中起重要作用;最后4)确定运动训练是否通过降低血管紧张素II和自由基使心力衰竭大鼠增强的心脏交感传入反射、增强的化学受体反射和钝化的压力受体反射正常化。这些反射相互作用调节心力衰竭时交感神经流出。心衰状态下交感神经兴奋异常可能由多种外周输入介导,中枢物质对其有重要调节作用。如果心脏交感传入反射和压力感受器反射是导致心衰交感神经激活的两种反射,那么全面了解这种反射的神经-体液调节可能会导致针对这种疾病状态的交感神经系统的更明确和合理的治疗。
英文摘要
DESCRIPTION (provided by applicant): Heart failure is characterized by an elevation in sympathetic tone. The mechanisms responsible for the sympatho-excitation in heart failure are not completely understood. Recent studies from this laboratory indicate that the cardiac "sympathetic afferent" reflex is enhanced and the baroreceptor reflex is blunted in heart failure. The augmented cardiac sympathetic afferent reflex and the blunted baroreceptor reflex are mediated by increases in central angiotensin II in heart failure. So far the mechanism(s) responsible for these reflex interactions in the heart failure state are not completely clear. Based on preliminary data we hypothesize that the augmentation of the cardiac sympathetic afferent reflex is mediated by central angiotensin II and reactive oxidant stress in the heart failure state. To better understand the mechanisms responsible for augmentation of the cardiac sympathetic afferent reflex we propose the following specific aims: 1) To determine if reactive oxygen species mediates the augmented cardiac sympathetic afferent reflex by elevated central angiotensin II in heart failure; 2) To determine if the cardiac sympathetic afferent reflex blunts the baroreceptor reflex and if the blunted baroreflex in animals with heart failure is restored by removal of cardiac sympathetic afferent input with epicardial application of lidocaine or depletion of cardiac sympathetic afferent neurotransmitters by the epicardial application of the ultrapotent neurotoxin resiniferatoxin, and to determine if central angiotensin II and free radicals play an important role in the blunted baroreceptor reflex by activation of the cardiac sympathetic afferent pathway in rats with heart failure; 3) To determine if the cardiac sympathetic afferent reflex augments the chemoreceptor reflex and if the enhanced chemoreceptor reflex in animals with heart failure is restored by removal of cardiac sympathetic afferent input with epicardial application of lidocaine or resiniferatoxin and to determine if central angiotensin II and free radicals play an important role in the chemoreceptor reflex by activation of cardiac sympathetic afferents in rats with heart failure; and finally 4) To determine if exercise training normalizes the enhanced cardiac sympathetic afferent reflex, the augmented chemoreceptor reflex, and the blunted baroreceptor reflex in rats with heart failure by decreasing angiotensin II and free radicals. These reflex interactions regulate sympathetic outflow in heart failure. The abnormal sympatho-excitation in the heart failure state is likely to be mediated by a variety of peripheral inputs with important modulation by central substances. If the cardiac sympathetic afferent reflex and baroreceptor reflex are two of the reflexes which contribute to sympathetic activation in heart failure, a comprehensive understanding of neuro-humoral regulation of this reflex may result in more definitive and rational therapy targeted to the sympathetic nervous system in this disease state.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Design of Fe2+ and H2O2 Induced Proximity Functionalized Imaging Probes for the Control of Cellular Functions
-
批准号:9918434
-
项目类别:
-
资助金额:$28.78万
-
财政年份:2019
-
负责人:WEI WANG
-
依托单位:
Design of Fe2+ and H2O2 Induced Proximity Functionalized Imaging Probes for the Control of Cellular Functions
-
批准号:10388365
-
项目类别:
-
资助金额:$28.72万
-
财政年份:2019
-
负责人:WEI WANG
-
依托单位:
Organocatalytic Practical Synthesis of Deuterated Building Blocks and Biologically Important Structures
-
批准号:9892834
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2018
-
负责人:WEI WANG
-
依托单位:
Organocatalytic Practical Synthesis of Deuterated Building Blocks and Biologically Important Structures
-
批准号:9918424
-
项目类别:
-
资助金额:$28.07万
-
财政年份:2018
-
负责人:WEI WANG
-
依托单位:
Organocatalytic Practical Synthesis of Deuterated Building Blocks and Biologically Important Structures
-
批准号:10115754
-
项目类别:
-
资助金额:$27.98万
-
财政年份:2018
-
负责人:WEI WANG
-
依托单位:
ICAM-1 MIMICS AS LFA-1 INHIBITORS
-
批准号:7960242
-
项目类别:
-
资助金额:$9.65万
-
财政年份:2009
-
负责人:WEI WANG
-
依托单位:
ICAM-1 MIMICS AS LFA-1 INHIBITORS
-
批准号:7720466
-
项目类别:
-
资助金额:$9.46万
-
财政年份:2008
-
负责人:WEI WANG
-
依托单位:
BINDING SPECIFICITY OF PEPTIDE RECOGNITION DOMAINS
-
批准号:7367782
-
项目类别:
-
资助金额:$2.21万
-
财政年份:2006
-
负责人:WEI WANG
-
依托单位:
A SYSTEMATIC APPROACH TO RECONSTRUCTING TRANSCRIPTION NETWORKS IN THE CELL
-
批准号:7180239
-
项目类别:
-
资助金额:$0.64万
-
财政年份:2005
-
负责人:WEI WANG
-
依托单位:
A SYSTEMATIC APPROACH TO RECONSTRUCTING TRANSCRIPTION
-
批准号:6976119
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2004
-
负责人:WEI WANG
-
依托单位:
CARDIAC SYMPATHETIC AFFERENT RELEX IN HEART FAILURE
-
批准号:6606558
-
项目类别:
-
资助金额:$14.25万
-
财政年份:2002
-
负责人:WEI WANG
-
依托单位:
CARDIAC SYMPATHETIC AFFERENT RELEX IN HEART FAILURE
-
批准号:6457667
-
项目类别:
-
资助金额:$14.25万
-
财政年份:2001
-
负责人:WEI WANG
-
依托单位:
DETERMINATION OF VAN DER WAALS COEFFICIENT DELTA IN LIE METHOD: DRUG DESIGN
-
批准号:6456824
-
项目类别:
-
资助金额:$27.32万
-
财政年份:2001
-
负责人:WEI WANG
-
依托单位:
DETERMINATION OF VAN DER WAALS COEFFICIENT DELTA IN LIE METHOD: DRUG DESIGN
-
批准号:6347986
-
项目类别:
-
资助金额:$1.32万
-
财政年份:2000
-
负责人:WEI WANG
-
依托单位:
CARDIAC SYMPATHETIC AFFERENT RELEX IN HEART FAILURE
-
批准号:6324754
-
项目类别:
-
资助金额:$15.32万
-
财政年份:2000
-
负责人:WEI WANG
-
依托单位:
CARDIAC SYMPATHETIC AFFERENT RELEX IN HEART FAILURE
-
批准号:6190983
-
项目类别:
-
资助金额:$15.32万
-
财政年份:1999
-
负责人:WEI WANG
-
依托单位:
DETERMINATION OF VAN DER WAALS COEFFICIENT DELTA IN LIE METHOD: DRUG DESIGN
-
批准号:6220356
-
项目类别:
-
资助金额:$1.32万
-
财政年份:1999
-
负责人:WEI WANG
-
依托单位:
NEW METHOD TO CALCULATE BINDING FREE ENERGY
-
批准号:6119282
-
项目类别:
-
资助金额:$0.54万
-
财政年份:1999
-
负责人:WEI WANG
-
依托单位:
NEW METHOD TO CALCULATE BINDING FREE ENERGY
-
批准号:6280303
-
项目类别:
-
资助金额:$3.99万
-
财政年份:1998
-
负责人:WEI WANG
-
依托单位:
CHEMICAL INFORMATION EXCHANGE SOFTWARE DEMONSTRATION
-
批准号:6250505
-
项目类别:
-
资助金额:$0.66万
-
财政年份:1997
-
负责人:WEI WANG
-
依托单位:
海外基金